Showing results (1-10 of 486) with videos related to
Sort By:
Pageof 49
Progress in Lipid Research|December 3, 2011
Chain length-specific properties of ceramidesSabine Grösch, Susanne Schiffmann, Gerd GeisslingerJournal of the National Cancer Institute|June 8, 2006
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitorsSabine Grösch, Thorsten Jürgen Maier, Susanne Schiffmann, et al.Progress in Lipid Research|May 17, 2016
The enigma of ceramide synthase regulation in mammalian cellsMarthe-Susanna Wegner, Susanne Schiffmann, Michael John Parnham, et al.European Journal of Pharmacology|May 30, 2006
Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatmentAstrid Janssen, Thorsten J Maier, Susanne Schiffmann, et al.Biochemical and Biophysical Research Communications|November 27, 2007
p53 is important for the anti-proliferative effect of ibuprofen in colon carcinoma cellsAstrid Janssen, Susanne Schiffmann, Kerstin Birod, et al.Expert Opinion on Investigational Drugs|November 15, 2016
Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory painSabine Grösch, Ellen Niederberger, Gerd GeisslingerBiochemical Pharmacology|May 30, 2008
Dimethylcelecoxib inhibits prostaglandin E2 productionIvonne Wobst, Susanne Schiffmann, Kerstin Birod, et al.Biochemical Pharmacology|June 13, 2008
The anti-proliferative potency of celecoxib is not a class effect of coxibsSusanne Schiffmann, Thorsten Jürgen Maier, Ivonne Wobst, et al.Journal of Lipid Research|August 20, 2008
The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesisSusanne Schiffmann, Jessica Sandner, Ronald Schmidt, et al.British Journal of Clinical Pharmacology|November 26, 2002
Validation of a new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German populationMaria Burian, Sabine Grösch, Irmgard Tegeder, et al.Pageof 49